CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attackStatus:In development | In consultationProgramme:Diagnostics guidanceConsultation end date: 26 April 2024Expected publication date: 10 July 2024
Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tenecteplase for treating acute ischaemic stroke [ID6306]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC